Mithra Pharmaceuticals
Liège
About Mithra Pharmaceuticals
Mithra Pharmaceuticals SA specializes in the development of women's health care products that are dedicated to the fields of contraception, fertility, and menopause. The two lead development candidates Estelle® (a fifth generation oral contraceptive) and Donesta® (a next generation hormone therapy) are built on Mithra's unique natural estrogen platform, E4 (Estetrol).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $182.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Feb 2024)
- Ticker: ebr:MITRA
- Website: mithra.comen
- Phone: +32 4 349 28 22
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/mithra-pharmaceuticals-175316 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.